Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study

Autor: José Antonio Pinto, Alex Fonollosa, Ester Carreño, Maria Isabel Rodriguez, David Diaz-Valle, Diana Peiteado, Luis Rodriguez-Rodriguez, Miguel Cordero-Coma, Marta Tejera Santana, Lidia Cocho, Ana Belen Rivas, Amanda Lopez-Picado, Valentina Calamia, Felix M Francisco Hernandez, Angel Garcia-Aparicio, Javier Garcia-Gonzalez, Jose Juan Mondejar, Leticia Lojo-Oliveira, Llucí Martínez-Costa, Santiago Munoz, Beatriz Rodriguez-Lozano, Esperanza Pato, Elena Molina, Luis Alberto Tebar, Mara Albert Fort, Mayte Ariño Gutierrez, Pedro Arriola Villalobos, Joseba Artaraz Beobide, Antonio Atanes Sandoval, Jose Manuel Sanchez, Francisco Blázquez, Pablo Borges Deniz, Lara Borrego Sanz, Gabriela Bustamante Sanchez-Arnedo, Bruno Casco Silva, Ricardo Cuiña Sardiña, Almudena De Pablo Cabrera, Maria Del Mar Esteban Ortega, Patricia Fernandez Puente, Dalifer Dayanira Nuñez, Javier Garcia Bella, Sara Garcia Carazo, Luis Garcia Onrubia, Jose Maria Morales, Jose Antonio Fernandez, Vanesa Hernandez Hernandez, Inés Hernanz Rodriguez, Jose Maria Cantalapiedra, Ventura Hidalgo Barrero, Maria De Jovani Casano, Sara López Sierra, Virginia Lozano Lopez, Alfredo Madrid Garcia, Rosalia Mendez Fernandez, Pilar Nozal Aranda, Eugenio Perez Blazquez, Chamaida Plasencia Rodriguez, Sheila Recuero Diaz, Ignacio Robles Barrena, Esther Rodriguez Almaraz, Fayna Maria Gonzalez, Guadalupe Rodriguez Martinez, Fredeswinda Isabel Bueno, Ioana Ruiz Arruza, Beatriz Sanchez Marugan, Olga Sanchez Pernaute, Armelle Schlinker Giraud, Alvaro Seijas Lopez, Patricia Simon Alonso, Elia Valls Pascual

Publikováno v: BMJ Open, Vol 12, Iss 3 (2022)

Introduction Non-infectious uveitis include a heterogeneous group of sight-threatening and incapacitating conditions. Their correct management sometimes requires the use of immunosuppressive drugs (ISDs), prescribed in monotherapy or in combination.

Externí odkaz: https://doaj.org/article/3d27a9e1d3f74fb69bbbda93ab9c84d7

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients

Autor: Nuria Barroso-García, Belén Atienza-Mateo, Iván Ferraz-Amaro, Diana Prieto-Peña, Emma Beltrán, Alfredo Adán, Marisa Hernández-Garfella, Lucía Martínez-Costa, Miguel Cordero-Coma, Manuel Díaz-Llopis, José M. Herreras, Olga Maíz-Alonso, Ignacio Torre-Salaberri, Ana De Vicente-Delmás, David Díaz-Valle, Antonio Atanes-Sandoval, Félix Francisco, Santos Insua, Julio Sánchez, Raquel Almodóvar-González, Alejandro Jiménez-Sosa, Oscar Ruiz-Moreno, Myriam Gandía-Martínez, Joan M. Nolla, Vanesa Calvo-Río, Santos Castañeda, Miguel A. González-Gay, Ricardo Blanco

Publikováno v: Seminars in Arthritis and Rheumatism. 58:152153

To compare the efficacy of TNF inhibitors (adalimumab (ADA) and infliximab (IFX)) vs tocilizumab (TCZ) in patients with refractory cystoid macular edema (CME) due to Behçet's disease (BD).Multicenter study of patients with BD-associated CME refracto

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6546d3a503f2a74e0b7a467a1a86b342
https://doi.org/10.1016/j.semarthrit.2022.152153

COMPARATIVE STUDY ON ANTI-TNF VS TOCILIZUMAB FOR TREATMENT OF REFRACTORY UVEITIC CYSTOID MACULAR EDEMA DUE TO BEHCET'S DISEASE. MULTICENTER STUDY OF 49 PATIENTS

Autor: Atienza-Mateo B, Ferraz-Amaro I, Catalan E, Adan A, Garfella M, Martinez-Costa L, Coma M, Diaz-Llopis M, Herreras J, Blanco A, Torre I, Diaz-Valle D, Atanes-Sandoval A, Hernandez F, Insua S, Sanchez J, Almodovar R, Ruiz-Moreno O, Martinez M, Nolla J, Martin-Varillas J, Calvo-Rio V, Prieto-Pena D, Gonzalez-Gay M, Blanco R

Publikováno v: ANNALS OF THE RHEUMATIC DISEASES
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Arthritis & Rheumatology
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
ARTHRITIS & RHEUMATOLOGY

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2cd6f667d12afb288aefd439c7048f38
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=12698

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.